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Abstract
Purpose
Hydrazine is carcinogenic in animals, but there is inadequate evidence to determine if it is
carcinogenic in humans. This study aimed to evaluate the association between hydrazine
exposure and the risk of lung cancer.
Methods
The cause specific mortality rates of a cohort of 427 men who were employed at an English
factory that produced hydrazine between 1945 and 1971 were compared with national mor-
tality rates.
Results
By the end of December 2012 205 deaths had occurred. For men in the highest exposure
category with greater than two years exposure and after more than ten years since first
exposure the relative risks compared with national rates were: 0.85 (95% CI: 0.18–2.48) for
lung cancer, 0.61 (95% CI: 0.07–2.21) for cancers of the digestive system, and 0.44 (95%
CI: 0.05–1.57) for other cancers.
Conclusions
After 50 years of follow up, the results provide no evidence of an increased risk of death
from lung cancer or death from any other cause.
Introduction
Hydrazine (N2H4) is a colourless flammable liquid with an ammonia-like odour. Hydrazine is
mainly used as a foaming agent in preparing polymer foams, but significant applications also
include its uses as a precursor to polymerisation catalysts and pharmaceuticals. Additionally,
hydrazine is used in various rocket fuels and to prepare the gas precursors used in air bags.
Hydrazine is used within both nuclear and conventional electrical power plant steam cycles as
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an oxygen scavenger to control concentrations of dissolved oxygen in an effort to reduce corro-
sion. Hydrazine is also used as a propellant on board space vehicles, and to both reduce the
concentration of dissolved oxygen in and control pH of water used in large industrial boilers.
The International Agency for Research on Cancer evaluated the evidence of the carcinoge-
nicity of hydrazine, and found that there is sufficient evidence in experimental animals but
there is inadequate evidence in humans. Their overall evaluation is that hydrazine is possible
carcinogenic to humans. Hydrazine was tested for carcinogenicity by oral administration to
mice in several experiments, producing mammary, lung and liver tumours. When tested by
oral administration or inhalation exposure in rats, it produced lung, liver and nasal tumours
and a few colon tumours. In hamsters, it produced liver tumours and thyroid adenomas follow-
ing oral or inhalation exposure [1–3].
Two previous reports on a cohort of 427 men who worked at a hydrazine plant in the East
Midlands region of England found no significant association with hydrazine exposure and
lung cancer [4–5]. In this paper we extend the follow-up to fifty years.
Methods
This is a study of a cohort of 427 men who worked in a hydrazine plant in the East Midlands
region of England between 1945 and 1971. The East Midlands is one of the nine official regions
of England, is the eastern part of the Midlands, and encompassed Nottinghamshire, Derby-
shire, Leicestershire, Rutland, Northamptonshire and most of Lincolnshire. The men were
employed for at least six months during the period of hydrazine production. The factory pro-
vided information on name, date of birth, date of first employment, date they left the company
and an estimate of the extent of hydrazine exposure. This exposure was estimated based on the
knowledge of the factory works manager. Further details of the hydrazine production at the
factory have been given in the previous reports [4–5].
Each type of employment was classified in one of three categories, according to the esti-
mated degree of exposure. High exposure was associated with the direct manufacture of hydra-
zine or its derivatives, or involved the use of liquid hydrazine as a raw material (1–10 ppm).
Moderate exposure was associated with an incidental presence in an area of the plant con-
cerned with the manufacture of hydrazine or its derivatives (<0.5 or 1 ppm). Men in the low
exposure category were unlikely to have been exposed to hydrazine more than slightly, and
then only infrequently.
Men who were first exposed in the low or moderate categories and who were subsequently
exposed in the high category contributed man-years at risk in the low or moderate categories
initially and to the high category after their first exposure in that category. Similarly, all men
who contributed man-years at risk>10 years after first exposure and for durations of exposure
of two years or more also contributed to man-years at risk<10 years after first exposure and to
less than two years’ duration of exposure.
The identifiable details of the men were used to flag their National Health Service records
with the Health & Social Care Information Centre (www.hscic.gov.uk). Quarterly, any death
certificates received by the Information Centre for the flagged men were then forwarded onto
the study team. Dates and cause of death were then extracted. The men were followed up to the
end of December 2012. The causes of death were coded using the International Classification
of Diseases versions 8, 9 and 10 (ICD 8, ICD 9 and ICD 10).
It was possible to trace 406 (95%) of the 427 men. The 21 remaining men were included in
the study until the last date they were known to have been living at their last known address, or
in the case of four men for whom this date was missing, until the last date of their employment
in the factory. These dates were all before July 1982 (the cut-off date for the first study).
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Person-years at risk and death rates were calculated by five-year age groups and time since
first exposure (<10 and10 years). The expected number of deaths was calculated from the
death rates of men in England and Wales in the same five-year age bands over the same period
of time. The observed and expected number of deaths were compared and tested for signifi-
cance with one sided Poisson tests.
The deaths rates in those men who had the greatest exposure (high exposure for more than
two years) were also compared to the death rates for all other men with Kaplan-Meier product
limit analysis. Analyses were carried out using STATA version 12 and Fortran.
This study received approval from the BMA Central & Ethical Committee, and from the
UK Patient Information Advisory Group to collect information from their employment and
their deaths certificates without consent to allow follow up of all cases. When this study was
started in the early 1980s this was the process required. This study was approved by the Direc-
tor of the Wolfson Institute of Preventive Medicine.
Results
This study is carried out on 427 men that worked at a hydrazine plant in the East Midlands
region of England. Their mean age at first exposure was 30 years (standard deviation (SD):
10.5), their mean length of total exposure was 6.8 years (SD: 6.3) and their mean length of fol-
low up (from last exposure to death, embarkation, last trace or end of the study) was 31.7 years
(SD: 16.4).
Table 1 shows the number of man-years under observation according to the category of
exposure, duration of exposure, and the number of years since first exposure. Of the 16,422
man-years 18% at risk were in the high exposure category.
Table 2 shows the number of deaths observed compared with the numbers expected. The
observed mortality is close to that expected for lung cancer, cancers of the digestive system,
other cancers, and ischaemic heart disease. For men in the highest exposure category the rela-
tive risks with greater than 2 years exposure and after more than 10 years since first exposure
Table 1. Number of men exposed andman-years at risk by category of exposure, duration of exposure, and years since first exposure.
Category Duration of exposure* Years since ﬁrst exposure Number of men Number of man-years
High‡  2 y < 10 54 502
 10 54 1297
< 2 y < 10 78 352
 10 78 770
All < 10 78 854
 10 78 2067
Moderate and low‡ All < 10 375 3365
 10 375 10137
All All < 10 507† 4219
 10 507 12203
* All men were exposed for  6 months.
† Men who at ﬁrst had low or moderate exposures and who were subsequently highly exposed contributed man-years at risk in the low or moderate
categories initially and to the high category after their ﬁrst exposure in that category. The numbers of men in each category, therefore, add up to more
than 427 in all, as some men contributed to more than one category. Similarly, all men who contributed man-years at risk  10 y after ﬁrst exposure and
for durations of exposure of  2 y also contributed to man-years at risk <10 y after ﬁrst exposure and to < 2 y duration of exposure.
‡ High = men who may have been exposed to about 1–10 ppm hydrazine vapour in the ambient air; moderate = men unlikely to have been exposed
to  1 ppm and probably < 0.5 ppm hydrazine vapour in the ambient air; low = men unlikely to have been exposed to hydrazine vapour.
doi:10.1371/journal.pone.0138884.t001
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Table 2. Number of deaths observed (O) and expected (E) by category of exposure, duration of exposure, years since first exposure, and cause.
Deaths
Cause of death Category of exposure Duration of exposure* Years since ﬁrst exposure O E O/E 95% CI
Lung High  2 y  10 3 3.53 0.85 0.18–2.48
cancer All 3 3.82 0.79 0.16–2.30
(162–163) All  10 6 4.55 1.32 0.48–2.87
All 6 4.90 1.22 0.45–2.67
Moderate or low All  10 11 17.91 0.61 0.31–1.10
All 11 18.86 0.58 0.29–1.04
All All  10 17 22.46 0.76 0.44–1.21
All 17 23.75 0.72 0.42–1.15
Cancer of High  2 y  10 2 3.27 0.61 0.07–2.21
digestive All 2 3.48 0.57 0.07–2.08
system All  10 2 4.33 0.46 0.06–1.67
(150–159) All 2 4.58 0.44 0.05–1.58
Moderate or low All  10 20 17.21 1.16 0.71–1.79
All 21 17.95 1.17 0.72–1.79
All All  10 22 21.53 1.02 0.64–1.55
All 23 22.54 1.02 0.65–1.53
Other High  2 y  10 2 4.59 0.44 0.05–1.57
cancer All 2 4.79 0.42 0.05–1.51
(140–149,160- All  10 2 6.13 0.33 0.04–1.18
161,164–239) All 2 6.40 0.31 0.04–1.13
Moderate or low All  10 19 23.84 0.80 0.48–1.24
All 20 24.71 0.81 0.49–1.25
All All  10 21 29.97 0.70 0.43–1.07
All 22 31.12 0.71 0.44–1.07
IHD High  2 y  10 11 11.57 0.95 0.47–1.70
(410–414) All 12 12.35 0.97 0.50–1.70
All  10 16 14.56 1.10 0.63–1.78
All 17 15.50 1.10 0.64–1.76
Moderate or low All  10 43 53.77 0.80 0.58–1.08
All 45 56.39 0.80 0.58–1.07
All All  10 59 68.33 0.86 0.66–1.11
All 62 71.89 0.86 0.66–1.11
Other High  2 y  10 11 20.15 0.55 0.27–0.98
Causes All 12 21.32 0.56 0.29–0.98
(000–139,240- All  10 11 25.18 0.44 0.22–0.78
409,415–999) All 12 26.80 0.45 0.23–0.78
Moderate or low All  10 65 84.19 0.77 0.60–0.98
All 69 89.19 0.77 0.60–0.98
All All  10 76 109.36 0.69 0.55–0.87
All 81 116.50 0.70 0.55–0.86
All High  2 y  10 29 43.11 0.67 0.45–0.97
Causes All 31 45.76 0.68 0.46–0.96
(000–999) All  10 37 54.74 0.68 0.48–0.93
All 39 58.18 0.67 0.48–0.92
Moderate or low All  10 158 196.91 0.80 0.68–0.94
All 166 207.62 0.80 0.68–0.93
(Continued)
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were: 0.85 (95% CI: 0.18–2.48) for lung cancer, 0.61 (95% CI: 0.07–2.21) for cancers of the
digestive system, 0.44 (95% CI: 0.05–1.57) for other cancers, and 0.95 (95% CI: 0.47–1.70) for
ischaemic heart disease.
The only categories in which the number of observed deaths exceeded expected deaths (but
not significantly) were lung cancer in men in the high exposure category for six months or
more (6 observed vs. 4.55 expected), cancers of the digestive system in men in the moderate or
low exposure category (20 observed vs. 17.21 expected) and ischaemic heart disease in men in
the high exposure category for six months or more (16 observed vs. 14.56 expected). Half of
the 6 deaths from lung cancer in men in the high exposure category were in men exposed in
that category for less than two years. Two deaths from cancer of the digestive system occurred
in men with exposure in the high exposure category compared to 3.27 expected.
Log rank test statistics from non-parametric survival analysis shows that men with the high-
est exposure did not seem to have significantly different mortality for lung cancer (p = 0.97),
cancers of the digestive system (p = 0.43) and all cancers (p = 0.69) compared with all the other
men in the study.
Discussion
The highest relative risk for the men in the highest exposure category for six months or more
was 1.32 (95% CI: 0.48–2.87) for lung cancer, which is comparable to the relative risk in the
previous studies, 1.23 (95% CI: 0.25–3.61) in 1995 study [5] and 1.60 (0.19–5.78) in the 1984
study [4]. It might be expected that the highest relative risk would be for those men with the
longest exposures ( 2years) and 10 years follow-up (to allow fully for the latency period of
lung cancer), but this relative risk was only 0.85 (0.18–2.48). This provides some reassurance
that despite the evidence of carcinogenicity in animals exposure at the levels observed in this
study is unlikely to pose a serious risk, if indeed there is any risk at all, for humans. For cancer
of the digestive system only 2 cases occurred amongst men with high exposures, the highest rel-
ative risk of 1,17 (0.72–1.79) corresponding to men with moderate or low exposures, similar to
the corresponding relative risk of 1.24 (0.47–2.70) in the 1995 study.
The strengths of this study are that this is one of very few datasets available on exposure to
hydrazine and there is now 50 years of follow up. This paper includes an additional 4758 (41%)
man-years of follow-up and an additional 119 (138%) deaths compared to the previous report.
However, the weakness is that it is a very small cohort so doesn’t have the power to detect very
low relative risks or increased risks for specific cancer. The cancers examined in this study were
limited to lung and digestive system due to the risks observed in animal studies.
It is possible that there could be a healthy worker effect in this data. It could also be that
hydrazine workers in this company were not able to smoke since hydrazine is flammable and a
dangerous fire and explosion hazard. This may explain the lack of increased risk for lung can-
cer and ischaemic heart disease.
Table 2. (Continued)
Deaths
Cause of death Category of exposure Duration of exposure* Years since ﬁrst exposure O E O/E 95% CI
All All  10 195 251.65 0.77 0.67–0.89
All 205 265.80 0.77 0.67–0.88
* All men were exposed for  6 months.
For category and duration of exposure see footnotes to Table 1. IHD = ischaemic heart disease.
doi:10.1371/journal.pone.0138884.t002
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Two reports on a cohort of aerospace workers showed workers with a greater hydrazine
exposure had an increased risk of death from lung cancer (RR = 1.45;95% CI:0.81–2.39), but
that the increased risks were not statistically significant and the upper 95% confidence interval
excluded a relative risk of more than 3 [6–7] An earlier study on the same cohort [8], had
found a significant effect, but they had assumed all test stand mechanics were exposed to
hydrazine, in the later studies they used a more precise exposure assessment [7]. A recent study
of a French cohort of uranium processing workers also showed a non-significant increased risk
of mortality from lung cancer after exposure to hydrazine (RR = 1.21; 95% CI: 0.68–2.17) [9],
Both of these results are not inconsistent with our results.
Despite the evidence of carcinogenicity in experimental animals, the level of exposures to
Hydrazine that men have experienced in this study were not associated with an excess risk of
cancer.
Conclusion
The numbers of men exposed to hydrazine in this study were small. The results obtained are
encouraging in that no obvious hazard from lung cancer or any other disease has appeared up
to 50 years later. The IARC current evaluation that hydrazine is possibly carcinogenic to
humans should not be changed by the results from this study. The results from this study do
not indicate an excess cancer risk associated with Hydrazine exposure, but the power of the
study is too limited to exclude small excess risks.
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